AstraZeneca reaffirms COVID-19 vaccine Covishield safety amidst rare side effect concerns

AstraZeneca reaffirms COVID-19 vaccine Covishield safety amidst rare side effect concerns

DNA

Published

In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while emphasising the vaccine's overall safety profile.

Full Article